Financial Performance - The company's revenue for Q1 2023 reached ¥5,946,849,853.43, representing a year-on-year increase of 27.16%[4] - Net profit attributable to shareholders was ¥496,753,444.07, reflecting a growth of 29.29% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses was ¥497,832,323.90, an increase of 25.66% year-on-year[4] - Basic and diluted earnings per share were both ¥0.52, up by 7.74% compared to the same quarter last year[4] - Operating profit for Q1 2023 was ¥684,089,734.63, compared to ¥492,391,244.39 in Q1 2022, reflecting a significant growth[18] - Net profit for Q1 2023 was ¥524,264,298.83, up from ¥383,511,524.40 in Q1 2022, indicating a year-over-year increase of 36.8%[18] - The total comprehensive income for Q1 2023 reached approximately ¥524.26 million, compared to ¥383.51 million in Q1 2022, indicating an increase of around 36.8%[19] - The basic and diluted earnings per share for Q1 2023 were both ¥0.52, up from ¥0.49 in Q1 2022, reflecting a growth of approximately 6.1%[19] Cash Flow and Assets - The net cash flow from operating activities amounted to ¥752,251,808.16, showing a 12.99% increase from the previous year[4] - Cash inflows from operating activities for Q1 2023 totaled approximately ¥7.08 billion, compared to ¥5.55 billion in Q1 2022, marking an increase of about 27.5%[21] - The net cash flow from operating activities for Q1 2023 was approximately ¥752.25 million, up from ¥665.78 million in Q1 2022, representing an increase of around 13%[21] - The cash outflow from investing activities in Q1 2023 was approximately ¥730.25 million, compared to ¥485.67 million in Q1 2022, indicating an increase of about 50.4%[22] - The net cash flow from financing activities for Q1 2023 was approximately -¥326.90 million, a decrease from -¥58.17 million in Q1 2022, reflecting a worsening of about 461.5%[22] - The cash and cash equivalents at the end of Q1 2023 were approximately ¥3.57 billion, down from ¥2.38 billion at the end of Q1 2022, indicating a decrease of about 50.5%[22] - The company reported cash and cash equivalents of approximately CNY 4.37 billion as of March 31, 2023, compared to CNY 4.49 billion at the end of 2022, indicating a decrease of about 2.7%[13] - Total current assets amounted to approximately CNY 10.52 billion as of March 31, 2023, compared to CNY 10.67 billion at the end of 2022, indicating a decrease of about 1.4%[13] Assets and Liabilities - Total assets at the end of the reporting period were ¥21,155,365,736.59, a slight increase of 1.51% from the end of the previous year[5] - Total assets as of Q1 2023 amounted to ¥21,155,365,736.59, compared to ¥20,841,243,241.84 at the end of Q1 2022, showing a growth of 1.5%[15] - Total liabilities for Q1 2023 were ¥13,571,375,768.81, down from ¥13,977,090,807.60 in Q1 2022, representing a decrease of 2.9%[15] - The company's goodwill increased to ¥2,592,585,969.68 in Q1 2023 from ¥2,363,756,298.38 in Q1 2022, marking an increase of 9.7%[14] - The total non-current assets reached ¥10,630,842,540.11 in Q1 2023, up from ¥10,171,611,760.85 in Q1 2022, indicating a growth of 4.5%[14] - Shareholders' equity attributable to the parent company was ¥6,713,652,430.64, up 8.08% from the previous year[5] - The company's equity attributable to shareholders increased to ¥6,713,652,430.64 in Q1 2023 from ¥6,211,882,358.99 in Q1 2022, a rise of 8.1%[15] Research and Development - Research and development expenses increased by 69.01%, indicating a focus on innovation and new product development[8] - Research and development expenses for Q1 2023 were ¥14,620,833.25, compared to ¥8,650,749.28 in Q1 2022, reflecting a 69.3% increase[18] - The company is actively pursuing new product development and technological advancements to enhance its competitive edge in the market[11] Mergers and Acquisitions - The company completed 7 mergers and acquisitions in the industry during the reporting period, involving a total of 371 stores, with 122 stores signed but not yet delivered[11] - The company invested CNY 10.8 million in a subsidiary, involving 10 stores, which is currently in progress[11] - The company completed the acquisition of a 51% stake in a pharmacy chain for CNY 17.1 million, involving 174 stores, which was finalized in February 2023[11] Inventory and Receivables - Inventory increased to approximately CNY 4.25 billion as of March 31, 2023, up from CNY 3.87 billion at the end of 2022, reflecting a growth of about 9.7%[13] - Accounts receivable rose to approximately CNY 1.04 billion as of March 31, 2023, compared to CNY 1.02 billion at the end of 2022, showing an increase of about 1.7%[13] Other Financial Information - The company reported a significant increase in asset impairment losses by 7521.88%, primarily due to inventory write-downs[8] - The company reported a total of CNY 132 million in other non-current financial assets as of March 31, 2023, unchanged from the previous period[13] - The total operating costs for Q1 2023 were ¥5,251,594,371.68, an increase from ¥4,174,595,435.40 in Q1 2022, reflecting a growth of 25.8%[16] - The company did not apply new accounting standards or interpretations for the first time in 2023[23]
大参林(603233) - 2023 Q1 - 季度财报